11.57
Amneal Pharmaceuticals Inc Borsa (AMRX) Ultime notizie
Is Amneal Pharmaceuticals Inc. stock trading near support levels2025 Risk Factors & Daily Chart Pattern Signals - newser.com
Will Amneal Pharmaceuticals Inc. stock outperform Dow Jones index2025 AllTime Highs & Safe Entry Point Alerts - newser.com
Is Amneal Pharmaceuticals Inc. stock oversold or undervaluedVolume Spike & Fast Exit Strategy with Risk Control - newser.com
Multi asset correlation models including Amneal Pharmaceuticals Inc.Weekly Trend Summary & Fast Entry High Yield Stock Tips - newser.com
Real time breakdown of Amneal Pharmaceuticals Inc. stock performancePortfolio Update Summary & AI Enhanced Trading Signals - newser.com
Candlestick signals on Amneal Pharmaceuticals Inc. stock todayMarket Weekly Review & Weekly High Conviction Ideas - newser.com
Is Amneal Pharmaceuticals Inc. stock ready for a breakoutPortfolio Performance Summary & Weekly High Return Stock Opportunities - newser.com
Why The Narrative Around Amneal Is Shifting Amid Analyst Revisions and Recent FDA Approvals - Yahoo Finance
Is Amneal Pharmaceuticals Inc. stock in correction or buying zoneMarket Sentiment Summary & Fast Moving Stock Trade Plans - newser.com
Amneal gets FDA nod for Iohexol Injection - MSN
Amneal Pharmaceuticals (AMRX): Valuation Perspective After FDA Greenlight for First Generic Omnipaque and Raised Guidance - Yahoo Finance
Amneal pharma exec Nikita Shah sells $1.57 million in stock By Investing.com - Investing.com Australia
FDA Approves First Generic Omnipaque: Might Change The Case For Investing In Amneal Pharmaceuticals (AMRX) - Yahoo Finance
Amneal pharma exec Nikita Shah sells $1.57 million in stock - Investing.com India
What analyst consensus says on Amneal Pharmaceuticals Inc. stockStock Surge & Momentum Based Trading Signals - newser.com
FDA approves Amneal’s generic iohexol injection for imaging procedures By Investing.com - Investing.com Australia
Amneal Pharmaceuticals' (NASDAQ:AMRX) Earnings May Just Be The Starting Point - simplywall.st
Piper Sandler Lifts Amneal Pharmaceuticals, Inc. (AMRX)’s Price Target To $13 Following Q3 Earnings Beat - MSN
Piper Sandler Lifts Amneal Pharmaceuticals, Inc. (AMRX)'s Price Target To $13 Following Q3 Earnings Beat - Finviz
Amneal gets FDA nod for Iohexol Injection (AMRX:NASDAQ) - Seeking Alpha
FDA approves Amneal’s generic iohexol injection for imaging procedures - Investing.com
Amneal Receives U.S. FDA Approval for Iohexol Injection - The Manila Times
Amneal (NASDAQ: AMRX) expects to launch first generic Omnipaque iohexol in Q1 2026 - Stock Titan
Published on: 2025-11-13 05:47:52 - newser.com
Is Amneal Pharmaceuticals Inc. stock a top momentum playPortfolio Gains Report & Daily Risk Controlled Trade Plans - newser.com
Amneal Pharmaceuticals stock reaches 52-week high at 11.89 USD By Investing.com - Investing.com Philippines
Is Amneal Pharmaceuticals Inc. stock resilient to inflationTrade Volume Summary & Long-Term Growth Plans - newser.com
Pfizer, Amneal, Jazz Pharmaceuticals, BD, and DaVita Shares Skyrocket, What You Need To Know - The Globe and Mail
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):